Children with high-threshold peanut allergies who gradually eat larger doses of store-bought peanut butter may achieve notably higher rates of desensitization compared to those who avoid peanuts, according to a recent study published in NEJM Evidence. The researchers recruited 73 children between the ages of 4 and 14 years old. The population of interest were all randomly assigned to either test the new treatment strategy or continue avoiding peanuts. Children in peanut-ingestion group were started with a minimum daily dose of 1/8 teaspoon of peanut butter and gradually increased their dose ...
Disparities in Allergy Care
Advertisement
After participation, the number of households filling epinephrine autoinjector prescriptions rose from 51% to 89%.
Patients with extreme anxiety about using their injectable delayed treatment by a mean of 4.3 hours from attack onset.
Black, Hispanic, and Asian patients were less likely to be started on subcutaneous allergen immunotherapy.
Medicaid was accepted by less than half of allergists in 13 states.
Women were more likely to have a positive oral challenge compared with men.
More than 60% of patients reported discontinuing treatment due to social factors.
The panel discusses how health care providers can be allies in addressing disparities in allergy care.
Dupilumab is a monoclonal antibody approved to treat atopic dermatitis in adolescents and children.
Advocacy includes directly supporting patients and influencing broader health policies at the community and national levels.
The risk of seizure was higher in children aged 6 to 24 months.
Advertisement
Expert Interviews
Urban Health Today reports on clinical news and policy updates that directly impact urban health care providers and their patients.
Get research and expert insights straight to your inbox.